The present study provided a new perspective on the immune escape mechanism of tumor cells, indicating that the therapeutic efficiency of DCs-based vaccination may be improved by coupling it with a blocking treatment of the VEGF-associated signaling pathway. Here, VEGFA is linked to neoplasm.